Global Wearable Injectors Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
Wearable Injectors Market Overview:
The Wearable Injectors Market was valued at $24 million in 2020 & is projected to reach $34 million by 2030. It is expected to grow at a 5% CAGR between 2021 and 2030.
Wearable Injectors Market Report offers in-depth insights, revenue details, and other vital information regarding the global wearable injectors market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.
The Wearable Injectors Market report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint.
The global wearable injectors market report has been segmented on the type, application, and region.
A wearable injector delivers drugs into the body that can't be administered using a standard handheld device.
Wearable Injectors Market Dynamics:
The increasing prevalence of chronic diseases, such as diabetes and cardiovascular diseases globally is a major factor expected to drive the growth of the global wearable injectors market over the forecast period.
In addition, a favorable reimbursement scenario, especially in developed countries is in turn expected to propel the growth of the target market over the forecast period.
The introduction of technological advancements products by manufacturers, with a view to gain a competitive edge, is another factor expected to support the growth of the target market over the forecast period.
However, availability and preference for alternative drug delivery modes are expected to hamper the growth of the global wearable injectors market over the forecast period.
In addition, unfavorable reimbursement scenario, especially in developing countries is another factor expected to limit the growth of the global wearable injectors market over the forecast period.
Companies operating the target market can focus on partnerships and collaborations, in order to develop advanced products which in turn creates lucrative growth opportunities.
Wearable Injectors Market Regional Analysis:
Market in North America accounted for a significant revenue share of the global wearable injectors market in terms of revenue contribution as compared to that of markets in other regions, in 2017.
The presence of well-developed healthcare infrastructure, coupled with the presence of key players are factors expected to boost the growth of the market in the region over the forecast period.
Europe accounts for the second-highest revenue share contribution to the global market, registering a share of XX.X%, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively.
In addition, the market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years.
The increasing prevalence of chronic diseases, especially in countries such as India and China, is a major factor expected to support the growth of the market in the region over the forecast period.
Increasing healthcare expenditure and growing adoption of advanced drug delivery systems are other major factors expected to boost the growth of the market in the region over the forecast period.
The markets in Latin America and Middle East & Africa are expected to register a moderate growth rate in the global wearable injectors market over the forecast period.
Wearable Injectors Market Segment Analysis:
On the basis of application, the target market is segmented based on oncology, diabetes, cardiovascular diseases, and other therapies. The increasing incidence of cancer globally is a major factor expected to drive the growth of the oncology segment over the forecast period.
Global Wearable Injectors Market Segmentation:
Segmentation on the basis of type:
- On-body injectors
- Off-body injectors
Segmentation on the basis of application:
- Cardiovascular Diseases
- Other Therapies (Parkinson’s disease, Thalassemia, etc.)
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Amgen Inc.
- Medtronic PLC
- Insulet Corporation
- Ypsomed Holding AG
- Becton, Dickinson and Company
- Tandem Diabetes Care, Inc.
- West Pharmaceutical Services, Inc.
- Valeritas, Inc.
- Enable Injections, LLC
- Steadymed Therapeutics, Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!